Applying network theory to epidemics: Control measures for Mycoplasma pneumoniae outbreaks

Emerging Infectious Diseases

Volumn 9, Issue 2, 2003, Pages 204-210

  Meyers, Lauren Ancel ^a,b   Newman, M E J ^a,c   Martin, Michael ^d   Schrag, Stephanie ^d  

^a SANTA FE INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAREGIVER; COMMUNITY; EPIDEMIC; INCUBATION TIME; INFECTION CONTROL; INFECTION PREVENTION; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; PREVALENCE; UNITED STATES;

EID: 0037324329     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0902.020188     Document Type: Article

References (17)

1. Bailey NTJ. The mathematical theory of infectious diseases. New York: Hafner Press; 1975.
2. May R, Anderson R. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press; 1992.
3. Hethcote HW. Mathematics of infectious diseases. SIAM Review 2000; 42:599-653.
4. Sattenspiel L, Simon CP. The spread and persistence of infectious diseases in structured populations. Math Biosci 1988;90:341-66.
5. Longini IM. A mathematical model for predicting the geographic spread of new infectious agents. Math Biosci 1988;90:367-83.
6. Kretzschmar M, Morris M. Measures of concurrency in networks and the spread of infectious disease. Math Biosci 1996;133:165-95.
7. Ball F, Mollison D, Scalia-Tomba G. Epidemics with two levels of mixing. The Annals of Applied Probability 1997;7:46-89.
8. Newman MEJ. Spread of epidemic disease on networks. Phys Rev E Stat Nonlin Soft Matter Phys 2002;66:016128.
9. Newman MEJ, Strogatz SH, Watts DJ. Random graphs with arbitrary degree distributions and their applications. Phys Rev E Stat Nonlin Soft Matter Phys 2001;64:026118.
10. Andersson H. Epidemic models and social networks. The Mathematical Scientist 1999;24:128-47.
11. Smith DJ, Forrest S, Ackley DH, Perelson AS. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci U S A 1999;96:14001-6.
12. Talkington DF, Waites KB, Schwartz SB, Besser RE. Emerging from obscurity: understanding pulmonary and extrapulmonary syndromes, pathogenesis, and epidemiology of human Mycoplasma pneumoniae infections. In: WM Scheld, WA Craig, JM Hughes, editors. Emerging infections. Washington: ASM Press; 2001.
13. Feikin DR, Moroney JF, Talkington DF, Thacker WL, Code JE, Schwartz LA, et al. An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and Adenovirus at a federal service training academy: new implications from an old scenario. Clin Infect Dis 1999;29:1545-50.
14. Hyde TB, Gilbert M, Schwartz SB, Zell ER, Watt JP, Thacker WL, et al. Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia. J Infect Dis 2001;183:907-12.
15. Gray GC, McPhate DC, Leinonen M, Cassell GH, Deperalta EP. Putnam SD, et al. Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease. Clin Infect Dis 1998;26:103-10.
16. Klausner JD, Passaro D, Rosenberg J, Thacker WL, Talkington DF, Werner SB, et al. Enhanced control of an outbreak of Mycoplasma pneumoniae pneunomia with azithromycin prophylaxis. J Infect Dis 1998;177:161-6.
17. Foy HM, Grayston JT, Kenny GE. Epidemiology of Mycoplasma pneumoniae infection in families. JAMA 1966;197:859-66.